SIEMENS HEALTHINEERS AG (SHL.DE) Stock Fundamental Analysis
Europe - FRA:SHL - DE000SHL1006 - Common Stock
45.25 EUR
+0.42 (+0.94%)
SHL gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 58 industry peers in the Health Care Equipment & Supplies industry. While SHL is still in line with the averages on profitability rating, there are concerns on its financial health. SHL has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
SHL had positive earnings in the past year.
In the past year SHL had a positive cash flow from operations.
SHL had positive earnings in each of the past 5 years.
Each year in the past 5 years SHL had a positive operating cash flow.
1.2 Ratios
With a decent Return On Assets value of 4.87%, SHL is doing good in the industry, outperforming 68.97% of the companies in the same industry.
SHL's Return On Equity of 12.29% is fine compared to the rest of the industry. SHL outperforms 77.59% of its industry peers.
With a decent Return On Invested Capital value of 7.89%, SHL is doing good in the industry, outperforming 72.41% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for SHL is below the industry average of 8.65%.
The 3 year average ROIC (5.87%) for SHL is below the current ROIC(7.89%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.87% | ||
| ROE | 12.29% | ||
| ROIC | 7.89% |
ROA(3y)3.87%
ROA(5y)4.27%
ROE(3y)9.76%
ROE(5y)10.27%
ROIC(3y)5.87%
ROIC(5y)6.49%
1.3 Margins
Looking at the Profit Margin, with a value of 9.29%, SHL is in the better half of the industry, outperforming 70.69% of the companies in the same industry.
In the last couple of years the Profit Margin of SHL has declined.
SHL's Operating Margin of 13.76% is fine compared to the rest of the industry. SHL outperforms 68.97% of its industry peers.
In the last couple of years the Operating Margin of SHL has declined.
SHL's Gross Margin of 38.76% is on the low side compared to the rest of the industry. SHL is outperformed by 75.86% of its industry peers.
In the last couple of years the Gross Margin of SHL has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.76% | ||
| PM (TTM) | 9.29% | ||
| GM | 38.76% |
OM growth 3Y-4.02%
OM growth 5Y-4.5%
PM growth 3Y-3.26%
PM growth 5Y-4.26%
GM growth 3Y-0.66%
GM growth 5Y-1.05%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SHL is still creating some value.
SHL has more shares outstanding than it did 1 year ago.
SHL has more shares outstanding than it did 5 years ago.
SHL has a better debt/assets ratio than last year.
2.2 Solvency
SHL has an Altman-Z score of 2.01. This is not the best score and indicates that SHL is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of SHL (2.01) is comparable to the rest of the industry.
The Debt to FCF ratio of SHL is 5.10, which is a neutral value as it means it would take SHL, 5.10 years of fcf income to pay off all of its debts.
SHL has a Debt to FCF ratio of 5.10. This is in the better half of the industry: SHL outperforms 60.34% of its industry peers.
SHL has a Debt/Equity ratio of 0.66. This is a neutral value indicating SHL is somewhat dependend on debt financing.
SHL has a worse Debt to Equity ratio (0.66) than 67.24% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 5.1 | ||
| Altman-Z | 2.01 |
ROIC/WACC1.31
WACC6.02%
2.3 Liquidity
SHL has a Current Ratio of 1.12. This is a normal value and indicates that SHL is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.12, SHL is doing worse than 72.41% of the companies in the same industry.
SHL has a Quick Ratio of 1.12. This is a bad value and indicates that SHL is not financially healthy enough and could expect problems in meeting its short term obligations.
SHL has a Quick ratio of 0.77. This is in the lower half of the industry: SHL underperforms 70.69% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.12 | ||
| Quick Ratio | 0.77 |
3. Growth
3.1 Past
SHL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.21%, which is quite good.
Measured over the past 5 years, SHL shows a small growth in Earnings Per Share. The EPS has been growing by 7.27% on average per year.
SHL shows a small growth in Revenue. In the last year, the Revenue has grown by 5.85%.
SHL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.02% yearly.
EPS 1Y (TTM)11.21%
EPS 3Y3.35%
EPS 5Y7.27%
EPS Q2Q%23.08%
Revenue 1Y (TTM)5.85%
Revenue growth 3Y7.51%
Revenue growth 5Y9.02%
Sales Q2Q%4.41%
3.2 Future
SHL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.80% yearly.
Based on estimates for the next years, SHL will show a small growth in Revenue. The Revenue will grow by 5.17% on average per year.
EPS Next Y9.58%
EPS Next 2Y8.35%
EPS Next 3Y9.57%
EPS Next 5Y9.8%
Revenue Next Year4.94%
Revenue Next 2Y4.73%
Revenue Next 3Y5.15%
Revenue Next 5Y5.17%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
SHL is valuated rather expensively with a Price/Earnings ratio of 19.01.
Compared to the rest of the industry, the Price/Earnings ratio of SHL indicates a rather cheap valuation: SHL is cheaper than 82.76% of the companies listed in the same industry.
SHL's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.32.
SHL is valuated rather expensively with a Price/Forward Earnings ratio of 17.28.
Based on the Price/Forward Earnings ratio, SHL is valued a bit cheaper than the industry average as 74.14% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of SHL to the average of the S&P500 Index (22.89), we can say SHL is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.01 | ||
| Fwd PE | 17.28 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, SHL is valued a bit cheaper than 67.24% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, SHL is valued cheaper than 86.21% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.59 | ||
| EV/EBITDA | 13.98 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
SHL has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.99
PEG (5Y)2.61
EPS Next 2Y8.35%
EPS Next 3Y9.57%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.01%, SHL has a reasonable but not impressive dividend return.
SHL's Dividend Yield is rather good when compared to the industry average which is at 2.14. SHL pays more dividend than 81.03% of the companies in the same industry.
SHL's Dividend Yield is comparable with the S&P500 average which is at 2.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.01% |
5.2 History
On average, the dividend of SHL grows each year by 6.35%, which is quite nice.
Dividend Growth(5Y)6.35%
Div Incr Years0
Div Non Decr Years6
5.3 Sustainability
SHL pays out 49.08% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of SHL is growing, but earnings are growing more, so the dividend growth is sustainable.
DP49.08%
EPS Next 2Y8.35%
EPS Next 3Y9.57%
FRA:SHL (9/26/2025, 7:00:00 PM)
45.25
+0.42 (+0.94%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners10.84%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap51.04B
Analysts83.7
Price Target61.88 (36.75%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.01% |
Yearly Dividend0.95
Dividend Growth(5Y)6.35%
DP49.08%
Div Incr Years0
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.66%
Min EPS beat(2)-2.04%
Max EPS beat(2)13.36%
EPS beat(4)3
Avg EPS beat(4)5.82%
Min EPS beat(4)-2.04%
Max EPS beat(4)13.36%
EPS beat(8)5
Avg EPS beat(8)3.25%
EPS beat(12)8
Avg EPS beat(12)3.67%
EPS beat(16)10
Avg EPS beat(16)2.87%
Revenue beat(2)1
Avg Revenue beat(2)-0.25%
Min Revenue beat(2)-0.77%
Max Revenue beat(2)0.27%
Revenue beat(4)2
Avg Revenue beat(4)-0.01%
Min Revenue beat(4)-0.81%
Max Revenue beat(4)1.29%
Revenue beat(8)3
Avg Revenue beat(8)-0.4%
Revenue beat(12)4
Avg Revenue beat(12)-0.45%
Revenue beat(16)8
Avg Revenue beat(16)0.12%
PT rev (1m)0.24%
PT rev (3m)-0.79%
EPS NQ rev (1m)-2.8%
EPS NQ rev (3m)-16.03%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.35%
Revenue NQ rev (1m)0.05%
Revenue NQ rev (3m)-4.82%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.71%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.01 | ||
| Fwd PE | 17.28 | ||
| P/S | 2.18 | ||
| P/FCF | 16.59 | ||
| P/OCF | 13.27 | ||
| P/B | 2.89 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.98 |
EPS(TTM)2.38
EY5.26%
EPS(NY)2.62
Fwd EY5.79%
FCF(TTM)2.73
FCFY6.03%
OCF(TTM)3.41
OCFY7.53%
SpS20.73
BVpS15.67
TBVpS-5.42
PEG (NY)1.99
PEG (5Y)2.61
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.87% | ||
| ROE | 12.29% | ||
| ROCE | 10.07% | ||
| ROIC | 7.89% | ||
| ROICexc | 8.64% | ||
| ROICexgc | 46.76% | ||
| OM | 13.76% | ||
| PM (TTM) | 9.29% | ||
| GM | 38.76% | ||
| FCFM | 13.16% |
ROA(3y)3.87%
ROA(5y)4.27%
ROE(3y)9.76%
ROE(5y)10.27%
ROIC(3y)5.87%
ROIC(5y)6.49%
ROICexc(3y)6.25%
ROICexc(5y)6.86%
ROICexgc(3y)30.57%
ROICexgc(5y)31.67%
ROCE(3y)7.49%
ROCE(5y)8.29%
ROICexcg growth 3Y-8.79%
ROICexcg growth 5Y-3.88%
ROICexc growth 3Y1.69%
ROICexc growth 5Y-10.54%
OM growth 3Y-4.02%
OM growth 5Y-4.5%
PM growth 3Y-3.26%
PM growth 5Y-4.26%
GM growth 3Y-0.66%
GM growth 5Y-1.05%
F-Score8
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 5.1 | ||
| Debt/EBITDA | 2.58 | ||
| Cap/Depr | 59.37% | ||
| Cap/Sales | 3.29% | ||
| Interest Coverage | 7.09 | ||
| Cash Conversion | 85.2% | ||
| Profit Quality | 141.62% | ||
| Current Ratio | 1.12 | ||
| Quick Ratio | 0.77 | ||
| Altman-Z | 2.01 |
F-Score8
WACC6.02%
ROIC/WACC1.31
Cap/Depr(3y)58.06%
Cap/Depr(5y)61.48%
Cap/Sales(3y)3.63%
Cap/Sales(5y)3.7%
Profit Quality(3y)91.88%
Profit Quality(5y)100.74%
High Growth Momentum
Growth
EPS 1Y (TTM)11.21%
EPS 3Y3.35%
EPS 5Y7.27%
EPS Q2Q%23.08%
EPS Next Y9.58%
EPS Next 2Y8.35%
EPS Next 3Y9.57%
EPS Next 5Y9.8%
Revenue 1Y (TTM)5.85%
Revenue growth 3Y7.51%
Revenue growth 5Y9.02%
Sales Q2Q%4.41%
Revenue Next Year4.94%
Revenue Next 2Y4.73%
Revenue Next 3Y5.15%
Revenue Next 5Y5.17%
EBIT growth 1Y18.19%
EBIT growth 3Y3.18%
EBIT growth 5Y4.12%
EBIT Next Year49.6%
EBIT Next 3Y21.79%
EBIT Next 5Y15.45%
FCF growth 1Y161.12%
FCF growth 3Y-1.94%
FCF growth 5Y15.48%
OCF growth 1Y86.79%
OCF growth 3Y-1.23%
OCF growth 5Y11.83%